Patents Examined by Mark W Bockelman
-
Patent number: 12268866Abstract: An implantable electrode system includes a controller device to treat apply electric field therapy (EFT) to a target structure according to specific anatomical properties of the target structure. The system enables selective association of contacts of the implantable electrode system with one or more target locations of varying tissue types within the body for application and measurement of EFT. The one or more target locations are associated with one or more anticipated tissue parameters that the implantable electrode system uses to apply and update waveform parameters to modulate EFT application from each respective contact to the one or more target locations.Type: GrantFiled: April 11, 2022Date of Patent: April 8, 2025Assignee: Dignity HealthInventor: Benjamin Hendricks
-
Patent number: 12268878Abstract: A device and algorithm for controlling an autonomic function in an individual. A controller device that utilizes physiological measurements (such as blood pressure) to regulate spinal cord electrical stimulation to stabilize blood pressure. A control interface and algorithm for controlling an autonomic function in a subject. For instance, an algorithm that utilizes physiological measurements (such as blood pressure) to regulate spinal cord electrical stimulation to stabilize blood pressure.Type: GrantFiled: December 16, 2021Date of Patent: April 8, 2025Assignee: THE UNIVERSITY OF BRITISH COLUMBIAInventors: Aaron Phillips, Andrei Krassioukov, Jordan Squair
-
Patent number: 12257430Abstract: An implantable electrical stimulation medical system is disclosed. The system includes an implantable medical device having electrical circuitry configured to perform electrical stimulation, a nonstandard implantable medical lead, and an adapter matrix. The adapter matrix electrically interfaces with the electrical circuitry and the nonstandard implantable medical lead to provide electrical stimulation from the implantable medical device to the nonstandard implantable medical lead.Type: GrantFiled: April 16, 2021Date of Patent: March 25, 2025Assignee: Medtronic, Inc.Inventors: Andrew Fried, Steve Deininger
-
Patent number: 12251557Abstract: An implantable electrode device is provided comprising a first layer and a second layer, the second layer being on top of the first layer and including at least one electrode contact. The at least one electrode contact is exposable to a nerve of a nervous tissue of a human or of an animal. A connecting means electrically connects the electrode contact, where the connecting means is made up of at least one conducting wire, and the conducting wire is arranged within the first layer and is fixed to the electrode contact.Type: GrantFiled: December 8, 2021Date of Patent: March 18, 2025Assignee: CorTec GmbHInventors: Andreas Marx, Miguel Ulloa
-
Patent number: 12246174Abstract: Chronic pain management can be achieved by electrically anesthetizing a peripheral nerve with on-demand electrical nerve block (OD-ENB). OD-ENB can be provided by an implantable capsule. Externally, at least a portion of the capsule can be constructed of a conductive membrane and the rest of the capsule comprises a biocompatible material. A blocking electrode contact, a return electrode contact, and a powering/communication component can be within the capsule. The blocking electrode contact can deliver a direct current (DC) through a portion of the conductive membrane to block conduction in the neural tissue to provide the OD-ENB. The return electrode contact can receive a return current from the neural tissue through another portion of the conductive membrane. The powering/communication component can communicate with one or more external components located external to the patient's body to receive a power signal. Notably the capsule has no internal battery.Type: GrantFiled: April 3, 2023Date of Patent: March 11, 2025Assignee: CASE WESTERN RESERVE UNIVERSITYInventors: Tina L. Vrabec, Kevin L. Kilgore, Jesse S. Wainright, Niloy Bhadra
-
Patent number: 12245974Abstract: A target volume of ocular tissue of an irido-corneal angle of an eye is treated by moving a focus of a laser through the target volume of ocular tissue, and photodisrupting the target volume of ocular tissue at a plurality of spots as the focus is moved through the target volume of ocular tissue. The focus is moved by transverse scanning the focus between at least one of: a first circumferential boundary and a second circumferential boundary of the target volume of ocular tissue, and a first azimuthal boundary and a second azimuthal boundary of the target volume of ocular tissue, and axial scanning the focus between a distal extent and a proximal extent of the target volume of ocular tissue.Type: GrantFiled: March 15, 2021Date of Patent: March 11, 2025Assignee: ViaLase, Inc.Inventors: Guy Holland, Tibor Juhasz, Eric R. Mikula, Ferenc Raksi, Manu Sharma, Hadi Srass, Carlos G. Suarez
-
Patent number: 12239452Abstract: A condition classifying device includes: an input interface configured to receive first data corresponding to a blood refilling state after ischemia of a subject, and second data corresponding to a physiological parameter that exhibits changes caused by vasodilation of the subject; a processor configured to perform a classification of a condition of the subject related to sepsis based on the first data and the second data; and an output interface configured to output a result of the classification.Type: GrantFiled: December 2, 2020Date of Patent: March 4, 2025Assignee: NIHON KOHDEN CORPORATIONInventor: Hideaki Hirabara
-
Patent number: 12220586Abstract: An implantable medical device performs a method that includes detecting a cardiac event interval that is greater than a P-wave oversensing threshold interval. In response to detecting the cardiac event interval greater than the P-wave oversensing threshold interval, the device determines the amplitude of the sensed cardiac signal and withholds restarting a pacing interval in response to the amplitude satisfying P-wave oversensing criteria. A pacing pulse may be generated in response to the pacing interval expiring without sensing an intrinsic cardiac electrical event that is not detected as a P-wave oversensing event.Type: GrantFiled: May 12, 2022Date of Patent: February 11, 2025Assignee: Medtronic, Inc.Inventors: Jian Cao, Alan Cheng
-
Patent number: 12214200Abstract: An example of an apparatus for percutaneously delivering neurostimulation energy to a patient and sensing from the patient using a test device placed externally to the patient is provided. The apparatus may include a stimulation lead, a sensing reference electrode, a sensing wire, and a connection system. The stimulation lead may be configured to be percutaneously introduced into the patient to place the one or more electrodes in the patient. The sensing reference electrode may be configured to be placed in the patient. The sensing wire may be connected to the sensing reference electrode and configured to be percutaneously introduced into the patient to place the sensing reference electrode in the patient. The connection system may be configured to mate the lead connector and the wire connector and to provide electrical connections between the lead connector and the test device and between the wire connector and the test device.Type: GrantFiled: May 10, 2023Date of Patent: February 4, 2025Assignee: Boston Scientific Neuromodulation CorporationInventors: Joseph M. Bocek, Michael X. Govea, Rosana Esteller
-
Patent number: 12214210Abstract: A leadless neurostimulation device having a header unit including at least one primary electrode having a contact surface that defines an external surface of the leadless neurostimulation device, a housing including a secondary electrode positioned on the same side of the leadless neurostimulation device as the at least one primary electrode, and a anchor device including at least one suture point for securing the leadless neurostimulation device to patient tissue or at least one protrusion nub configured to create mechanical resistance that impedes relative movement between wherein the leadless neurostimulation device and the patient tissue when implanted, where the at least one primary electrode and the secondary electrode are configured to transmit an electrical stimulation signal therebetween to provide electrical stimulation therapy to a target nerve of a patient.Type: GrantFiled: September 24, 2021Date of Patent: February 4, 2025Assignee: Medtronic, Inc.Inventors: Steven T. Deininger, Jerel K. Mueller, Todd V. Smith, Jeffrey Clayton, Thomas M. Hillebrand, Phillip C. Falkner, Jenna N. George, Sarah J. Offutt
-
Patent number: 12171516Abstract: Systems and methods for minimally invasive computer-assisted telesurgery are described. A computer-assisted teleoperated surgery system includes a teleoperated instrument actuation pod. The surgical instrument actuation pod includes a plurality of linear actuators arranged around a surgical instrument. The linear actuators engage with actuator engagement members on the instrument and so drive movable parts on the instrument. The actuation pod is mounted on a teleoperated manipulator. Instrument pod mass is close to the teleoperated manipulator to minimize the pod's inertia, momentum, and gravity effects on the manipulator.Type: GrantFiled: December 3, 2021Date of Patent: December 24, 2024Assignee: INTUITIVE SURGICAL OPERATIONS, INC.Inventors: Ryan Charles Abbott, John Ryan Steger, Daniel H. Gomez, Ian E. McDowall, Amy Kerdok
-
Patent number: 12144976Abstract: The invention relates to a method for detecting a state of wear of a cardiac support system. The method comprises a read-in step and a determination step. During the read-in step, a sensor signal (315) representing an operating state of the cardiac support system is read in. During the determination step, a wear signal (325) is determined using the sensor signal (315) and a comparison rule (320). The wear signal (325) represents the wear condition.Type: GrantFiled: June 21, 2019Date of Patent: November 19, 2024Assignee: Kardion GmbHInventors: Hardy Baumbach, Julian Kassel, Inga Schellenberg, Ricardo Ehrenpfordt, Marc Schmid, Ahmad Mansour, Martina Budde, Thomas Alexander Schlebusch
-
Patent number: 12144632Abstract: In various examples, a component for a medical device is described. The component includes a conductor wire including a connection portion. An electrode is formed from a conductive tube. The conductive tube is compressed at least partially around the connection portion of the conductor wire to at least partially surround and couple to the connection portion.Type: GrantFiled: August 1, 2023Date of Patent: November 19, 2024Assignee: Greatbatch Ltd.Inventors: Hugh D. Hestad, Jeff Fleigle, Christopher Mauhar, Krishna Vedula, Hitesh Mehta, Rommy U. Huleis
-
Patent number: 12144694Abstract: The invention relates to a flexible electrode (8) made of a metal base material (10) with a coating (18) made of polycrystalline doped electrically conductive diamond and an intermediate layer (20) between the base material (10) and the coating (18), wherein the base material (10) is in the form of a needle or wire, wherein at least one circumferential, circular or spiral groove (12) is formed in the base material (10) about a longitudinal axis (17) of the base material (10).Type: GrantFiled: April 6, 2020Date of Patent: November 19, 2024Assignee: BD-4 GMBHInventors: Stefan Rosiwal, Matthias Karl, Andreas Burkovski, Maximilian Goeltz
-
Patent number: 12127853Abstract: Aspects relate to a physiological parameter sensor helmet. The physiological parameter sensor helmet includes at least a helmet including a bone conducting transducer; at least a physiological sensor installed within the at least a helmet, wherein the physiological sensor is configured to measure a plurality of physiological parameters of a user, wherein the plurality of physiological parameters includes at least a plurality of blood oxygenation signals; a computing device in communication with the physiological sensor and including: at least a processor; and a memory communicatively connected to the at least a processor, the memory containing instructions configuring the at least a processor to: receive the plurality of physiological parameters from the physiological sensor; and generate a health profile as a function of the plurality of physiological parameters.Type: GrantFiled: October 4, 2022Date of Patent: October 29, 2024Inventors: Brad Everman, Brian Bradke
-
Patent number: 12121723Abstract: Presented herein are techniques for electrically stimulating a recipient's vestibular nerve in order to mask vestibular noise signals (vestibular noise) generated by the peripheral vestibular system (e.g., prevent erroneous balance information generated by the peripheral vestibular system from being sent to the brain of the recipient). A vestibular nerve stimulator in accordance with embodiments presented herein includes a plurality of electrodes implanted in an inner ear of a recipient at a location that is adjacent to the otolith organs of the inner ear. The vestibular nerve stimulator is configured to generate one or more continuous pulse trains and to deliver the one or more continuous pulse trains to the inferior branch of the recipient's vestibular nerve.Type: GrantFiled: April 28, 2022Date of Patent: October 22, 2024Assignee: Universidad de Las Palmas de Gran CanariaInventors: Angel Manuel Ramos Macias, Angel Ramos de Miguel
-
Patent number: 12114938Abstract: The present invention provides a medical robot which is hygienic and capable of precisely transferring a catheter, a driving device mounted on the medical robot, and a roller module mounted on the driving device. The roller module includes: a driving unit; and a roller unit rotated about the vertical axis by the driving unit, wherein the roller unit includes at least one roller and at least one shaft independently coupled to the at least one roller of the roller unit and rotated by the driving unit, wherein at least one groove is formed on the at least one roller of the roller unit and at least a part of the at least one shaft of the roller unit is disposed on the at least one groove.Type: GrantFiled: October 16, 2020Date of Patent: October 15, 2024Assignee: LN ROBOTICS INC.Inventors: Jae Soon Choi, Young Hak Kim, Young Jin Moon
-
Patent number: 12119759Abstract: This application describes a variety of approaches for generating high voltage sinusoidal signals whose output voltage can be adjusted rapidly, without introducing high-frequency artifacts on the output. When these approaches are used, stronger electric fields can be applied to the tumor for a higher percentage of time, which can increase the efficacy of TTFields therapy. In some embodiments, this is accomplished by preventing adjustments to a DC power source during times when the output of that DC power source is powering the output signal. In some embodiments, this is accomplished by synchronizing the operation of an AC voltage generator and an electronic switch that is connected to the output of the AC voltage generator.Type: GrantFiled: February 2, 2023Date of Patent: October 15, 2024Assignee: Novocure GmbHInventor: Yoram Wasserman
-
Patent number: 12109149Abstract: A system includes a radiation source and a controller. The controller is configured to designate, for irradiation, multiple target regions on an eye of a patient, and to perform an iterative process that includes, during each iteration of the process, acquiring an image of the eye, based on the image, calculating a location of a different respective one of the target regions, processing the image so as to identify any obstruction at the location, and provided no obstruction at the location is identified, causing the radiation source to irradiate the location. Other embodiments are also described.Type: GrantFiled: December 29, 2020Date of Patent: October 8, 2024Assignee: BELKIN VISION LTD.Inventors: Zachary Sacks, Daria Lemann-Blumenthal, Daniel Elkayam, Masha Dobkin-Bekman
-
Patent number: 12109410Abstract: Described is a low voltage, pulsed electrical stimulation device for controlling expression of, for example, follistatin, a muscle formation promotion protein, by tissues. Epicardial stimulation is especially useful for heart treatment. Follistatin controlled release is also useful for treating other ailments, such as erectile dysfunction, aortic aneurysm, and failing heart valves.Type: GrantFiled: March 29, 2021Date of Patent: October 8, 2024Assignee: LEONHARDT VENTURES LLCInventors: Howard J. Leonhardt, Jorge Genovese